The OBN Awards are taking place in Oxford on Thursday 5th October and we are delighted to announce the names of our official judging panel members who have kindly agreed to contribute to the awards process by assessing our finalists and choosing the winners.
The panel features some im
pressive names from across the industry, including:
Bryan Morton, Executive Chair - EUSA Pharma & VH2;
Dara Henry, Director, Immunology Innovation Fund - GSK;
Sue Charles, Managing Partner - Instinctif Partners;
Andrew McLean, Lead Life Sciences Investor - Oxford Sciences Innovation;
Ewa Truchanowicz, Business Engagement Manager - The BioHub Birmingham;
Alan O'Connell, Partner - Seroba Life Sciences;
John Chaddock, Vice President Neurology, Site Head - Ipsen Bioinnovation;
Bill Fleming, CFO - Oxitec;
Caroline Barelle, CEO - Elasmogen;
Anton Hutter, Partner & Patent Attorney - Venner Shipley and
Etienne Vervaecke, General Manager- Eurasante
If you want to be in with a chance of being recognised and celebrated at our Awards, make sure you submit your entry before the deadline on 30 June. Full details and the entry form can be found
For updated information on event sponsors please visit our awards website.